CN1362957A - 作为抗肿瘤剂的c7杂取代乙酸酯取代的紫杉烷 - Google Patents

作为抗肿瘤剂的c7杂取代乙酸酯取代的紫杉烷 Download PDF

Info

Publication number
CN1362957A
CN1362957A CN01800318A CN01800318A CN1362957A CN 1362957 A CN1362957 A CN 1362957A CN 01800318 A CN01800318 A CN 01800318A CN 01800318 A CN01800318 A CN 01800318A CN 1362957 A CN1362957 A CN 1362957A
Authority
CN
China
Prior art keywords
pyridyl
taxane
furyl
thienyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01800318A
Other languages
English (en)
Chinese (zh)
Inventor
R·A·霍尔顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University Research Foundation Inc
Original Assignee
Florida State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation Inc filed Critical Florida State University Research Foundation Inc
Publication of CN1362957A publication Critical patent/CN1362957A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
CN01800318A 2000-02-02 2001-02-02 作为抗肿瘤剂的c7杂取代乙酸酯取代的紫杉烷 Pending CN1362957A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17967200P 2000-02-02 2000-02-02
US60/179,672 2000-02-02

Publications (1)

Publication Number Publication Date
CN1362957A true CN1362957A (zh) 2002-08-07

Family

ID=22657505

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01800318A Pending CN1362957A (zh) 2000-02-02 2001-02-02 作为抗肿瘤剂的c7杂取代乙酸酯取代的紫杉烷

Country Status (20)

Country Link
US (3) US6673833B2 (enExample)
EP (1) EP1200424B1 (enExample)
JP (1) JP2003522169A (enExample)
KR (1) KR20010112393A (enExample)
CN (1) CN1362957A (enExample)
AT (1) ATE413397T1 (enExample)
AU (1) AU776765B2 (enExample)
BR (1) BR0104353A (enExample)
CA (1) CA2368534A1 (enExample)
CZ (1) CZ20013519A3 (enExample)
DE (1) DE60136430D1 (enExample)
HK (1) HK1047935A1 (enExample)
HU (1) HUP0200651A3 (enExample)
IL (1) IL145642A0 (enExample)
MX (1) MXPA01009922A (enExample)
NO (1) NO20014758L (enExample)
NZ (1) NZ514411A (enExample)
PL (1) PL350328A1 (enExample)
WO (1) WO2001057029A1 (enExample)
ZA (1) ZA200108063B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1712399B (zh) * 2004-06-24 2010-08-11 中国医学科学院药物研究所 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200424B1 (en) * 2000-02-02 2008-11-05 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
US20040210289A1 (en) * 2002-03-04 2004-10-21 Xingwu Wang Novel nanomagnetic particles
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
CA2494074A1 (en) * 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
CN1960721A (zh) * 2004-03-05 2007-05-09 佛罗里达州立大学研究基金有限公司 C7乳酰氧基取代的紫杉烷类
US20050249667A1 (en) * 2004-03-24 2005-11-10 Tuszynski Jack A Process for treating a biological organism
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US9085605B2 (en) 2010-05-27 2015-07-21 Shenzhen Salubris Pharmaceuticals Co., Ltd. Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879929A (en) * 1988-06-06 1989-11-14 Roth Alfred C Tapper/threader assembly
US4950790A (en) * 1988-11-14 1990-08-21 Air Products And Chemicals, Inc. Volatile fluorinated β-ketoimines and associated metal complexes
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5243253A (en) * 1991-07-30 1993-09-07 Thomson Consumer Electronics, Inc. Color picture tube having shadow mask with improved tie bar grading
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
SG46582A1 (en) 1991-09-23 1998-02-20 Univ Florida State 10-Desacetoxytaxol derivatives
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5250683A (en) 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
ATE195973T1 (de) 1992-01-15 2000-09-15 Squibb & Sons Inc Enzymatische verfahren zur resolution von enantiomeren-mischungen nützlich wie zwischenprodukte zur herstellung von taxanen
DE4302686C2 (de) 1992-02-05 1994-12-15 Bierther Hans Dietmar Hochleistungsventil
FR2687150B1 (fr) 1992-02-07 1995-04-28 Rhone Poulenc Rorer Sa Procede de preparation de derives du taxane.
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
US5200534A (en) 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
ATE232871T1 (de) * 1993-03-22 2003-03-15 Univ Florida State Taxane mit furyl-oder thienyl substituierten seitenketten
US5350253A (en) * 1993-03-24 1994-09-27 John Cunningham Method for supporting distribution means
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
EP0788493A1 (en) * 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
US5767297A (en) * 1997-02-05 1998-06-16 Ensuiko Sugar Refining Co., Ltd. Taxoid derivative and method of producing thereof
JP3786462B2 (ja) * 1996-03-07 2006-06-14 塩水港精糖株式会社 タキソイドの配糖化誘導体およびその製造方法
WO1997042181A1 (en) 1996-05-06 1997-11-13 Florida State University 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5780683A (en) * 1996-09-11 1998-07-14 Abb Lummus Global Inc. Cyclohexane oxidation
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
HU224589B1 (hu) * 1997-06-03 2005-11-28 Ensuiko Sugar Refining Co., Ltd. Taxoidszármazékok és eljárás előállításukra
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US6136988A (en) 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same
EP1200424B1 (en) * 2000-02-02 2008-11-05 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
KR20010111580A (ko) 2000-02-02 2001-12-19 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 개선된 용해도를 갖는 탁산 제형물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1712399B (zh) * 2004-06-24 2010-08-11 中国医学科学院药物研究所 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途

Also Published As

Publication number Publication date
HUP0200651A2 (hu) 2002-07-29
HK1047935A1 (zh) 2003-03-14
ZA200108063B (en) 2003-12-01
NO20014758D0 (no) 2001-10-01
NZ514411A (en) 2005-02-25
JP2003522169A (ja) 2003-07-22
IL145642A0 (en) 2002-06-30
EP1200424A1 (en) 2002-05-02
US20020065305A1 (en) 2002-05-30
US20050143446A1 (en) 2005-06-30
US7183312B2 (en) 2007-02-27
MXPA01009922A (es) 2003-07-14
WO2001057029A1 (en) 2001-08-09
EP1200424B1 (en) 2008-11-05
US20040087547A1 (en) 2004-05-06
CZ20013519A3 (cs) 2002-04-17
HUP0200651A3 (en) 2002-10-28
AU3480401A (en) 2001-08-14
NO20014758L (no) 2001-11-29
ATE413397T1 (de) 2008-11-15
KR20010112393A (ko) 2001-12-20
BR0104353A (pt) 2002-04-16
CA2368534A1 (en) 2001-08-09
DE60136430D1 (de) 2008-12-18
AU776765B2 (en) 2004-09-23
PL350328A1 (en) 2002-12-02
US6673833B2 (en) 2004-01-06
US6861446B2 (en) 2005-03-01

Similar Documents

Publication Publication Date Title
KR100784161B1 (ko) 항종양제로서 c7 에스테르 치환된 탁산
US6664275B2 (en) C10 heterosubstituted acetate taxanes
KR20020002416A (ko) 항종양제로서 c10 에스테르 치환된 탁산
CN1186340C (zh) 用作抗肿瘤剂的c10碳酸酯取代的紫杉烷
KR20010111580A (ko) 개선된 용해도를 갖는 탁산 제형물
CN1362957A (zh) 作为抗肿瘤剂的c7杂取代乙酸酯取代的紫杉烷
HK1047934A1 (zh) 用作抗肿瘤剂的c7碳酸酯取代的紫杉烷
HK1047936A1 (zh) C10氨基甲酰氧基取代的紫衫烷抗肿瘤剂
CN1380882A (zh) 作为抗肿瘤剂的c10酯取代的紫杉烷
HK1047937A1 (zh) C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂
US7160919B2 (en) C7 lactyloxy-substituted taxanes
HK1049670A (en) C10 ester substituted taxanes as antitumor agents
HK1053472B (en) C10 carbonate substituted taxanes as antitumor agents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1047935

Country of ref document: HK